Cargando…

Radiation enhancing effects of sanazole and gemcitabine in hypoxic breast and cervical cancer cells in vitro

AIM OF THE STUDY: Sanazole and gemcitabine have been proven clinically as hypoxic cell radiosensitisers. This study was conducted to determine the radiation enhancing effects of sanazole and gemcitabine when administered together at relevant concentrations into hypoxic human MCF-7 and HeLa cells. MA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zeng, Yue-Can, Wu, Rong, Xiao, Yu-Ping, Xin, Yan, Chi, Feng, Xing, Rui, Xue, Ming, Wang, Nai-Qian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2015
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631282/ https://www.ncbi.nlm.nih.gov/pubmed/26557765 http://dx.doi.org/10.5114/wo.2015.51820

Ejemplares similares

High Efficacy of Preoperative Low-Dose Radiotherapy with Sanazole (AK-2123) for Extraskeletal Ewing's Sarcoma: A Case Report
por: Sakabe, Tomoya, et al.
Publicado: (2011)

Cost effectiveness of concurrent gemcitabine and cisplatin and radiation followed by adjuvant gemcitabine and cisplatin in stages IIB–IVA cervical cancer
por: Rajan, Narayan, et al.
Publicado: (2014)

Gemcitabine-Induced Radiation Recall Phenomenon in Cervical Cancer: A Case Report
por: Carvalho, Jesus Paula, et al.
Publicado: (2023)

Comparison of bacterial community structure and potential functions in hypoxic and non-hypoxic zones of the Changjiang Estuary
por: Wu, Dong-Mei, et al.
Publicado: (2019)

In vitro synergistic cytotoxicity of gemcitabine and pemetrexed and pharmacogenetic evaluation of response to gemcitabine in bladder cancer patients
por: Mey, V, et al.
Publicado: (2006)

Perinatal Hypoxic-Ischemic Encephalopathy
por: Lai, Ming-Chi, et al.
Publicado: (2011)

Huaier increases the antitumor effect of gemcitabine on pancreatic cancer in vitro and in vivo
por: Chen, Tao, et al.
Publicado: (2021)

Gene delivery to hypoxic cells in vitro
por: Dachs, G U, et al.
Publicado: (2000)

Transcriptome changes induced by RUNX3 in cervical cancer cells in vitro
por: Gao, Qian-Qian, et al.
Publicado: (2020)

Digoxin sensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine via inhibiting Nrf2 signaling pathway
por: Zhou, Yunjiang, et al.
Publicado: (2019)

Gemcitabine-Induced Radiation Recall Myositis: Case Report and Review of the Literature
por: Ravishankar, Adarsh, et al.
Publicado: (2018)

Gemcitabine potentiates the anti-tumour effect of radiation on medullary thyroid cancer
por: Sandblom, Viktor, et al.
Publicado: (2019)

Role of hypoxic exosomes and the mechanisms of exosome release in the CNS under hypoxic conditions
por: Yang, Rong, et al.
Publicado: (2023)

Transcatheter arterial chemoembolization with gemcitabine and oxaliplatin for the treatment of advanced biliary tract cancer
por: Zhao, Qing, et al.
Publicado: (2015)

Astaxanthin inhibits gemcitabine-resistant human pancreatic cancer progression through EMT inhibition and gemcitabine resensitization
por: Yan, Tao, et al.
Publicado: (2017)

κ-Opioid Receptor Stimulation Improves Endothelial Function in Hypoxic Pulmonary Hypertension
por: Wu, Qi, et al.
Publicado: (2013)

DNA Methylation-Independent Reversion of Gemcitabine Resistance by Hydralazine in Cervical Cancer Cells
por: Candelaria, Myrna, et al.
Publicado: (2012)

Effectiveness of Concomitant Chemoradiotherapy with Gemcitabine in Locally Advanced Cervical Cancer Patients with Comorbidities
por: Brau-Figueroa, Hasan, et al.
Publicado: (2022)

Strategies To Assess Hypoxic/HIF-1-Active Cancer Cells for the Development of Innovative Radiation Therapy
por: Yeom, Chan Joo, et al.
Publicado: (2011)

Synergistic Anticancer Effects of Gemcitabine with Pitavastatin on Pancreatic Cancer Cell Line MIA PaCa-2 in vitro and in vivo
por: Chen, Ya-Hui, et al.
Publicado: (2020)

Establishment and characterization of the gemcitabine-resistant human pancreatic cancer cell line SW1990/gemcitabine
por: Yu, Yue, et al.
Publicado: (2019)

Efficient Delivery of Gemcitabine by Estrogen Receptor-Targeted PEGylated Liposome and Its Anti-Lung Cancer Activity In Vivo and In Vitro
por: Tang, Huan, et al.
Publicado: (2023)

Gemcitabine plus concurrent irreversible electroporation vs gemcitabine alone for locally advanced pancreatic cancer
por: Ma, Yang-Yang, et al.
Publicado: (2020)

In vitro and in vivo efficacy of afatinib as a single agent or in combination with gemcitabine for the treatment of nasopharyngeal carcinoma
por: Xue, Cong, et al.
Publicado: (2016)

OSI-027 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabine both in vitro and in vivo
por: Zhi, Xiao, et al.
Publicado: (2015)

Regarding the study testing the addition of gemcitabine to concurrent chemoradiotherapy in cervical carcinoma: Clarity needed
por: Revannasiddaiah, Swaroop, et al.
Publicado: (2013)

Oncogenic transformation in vitro by the hypoxic cell sensitizer misonidazole.
por: Miller, R. C., et al.
Publicado: (1978)

S-phase–specific radiosensitization by gemcitabine for therapeutic carbon ion exposure in vitro
por: Harrabi, Semi B., et al.
Publicado: (2016)

Antitumor activity of gemcitabine against high-grade meningioma in vitro and in vivo
por: Takeda, Hiroyuki, et al.
Publicado: (2017)

Targeting radiation-resistant hypoxic tumour cells through ATR inhibition
por: Pires, I M, et al.
Publicado: (2012)

The Hypoxic Microenvironment of Breast Cancer Cells Promotes Resistance in Radiation Therapy
por: Gilreath, Cordell, et al.
Publicado: (2021)

Schedule dependent synergy of gemcitabine and doxorubicin: Improvement of in vitro efficacy and lack of in vitro‐in vivo correlation
por: Vogus, Douglas R., et al.
Publicado: (2018)

Imaging Features of Symptomatic Radiation-induced Cervical Artery Stenosis
por: Xu, Jia-Ping, et al.
Publicado: (2017)

microRNA-378 promotes mesenchymal stem cell survival and vascularization under hypoxic–ischemic conditions in vitro
por: Xing, Yue, et al.
Publicado: (2014)

Curcumin enhances anti-cancer efficacy of either gemcitabine or docetaxel on pancreatic cancer cells
por: Liu, Pan, et al.
Publicado: (2020)

Timing of chemotherapy-induced neutropenia: the prognostic factor in advanced pancreatic cancer patients treated with gemcitabine / gemcitabine-based chemotherapy
por: Chen, Yang, et al.
Publicado: (2017)

Radiation-responsive scintillating nanotheranostics for reduced hypoxic radioresistance under ROS/NO-mediated tumor microenvironment regulation
por: Dou, Yan, et al.
Publicado: (2018)

Addition of gemcitabine to standard therapy in locally advanced cervical cancer: A randomized comparative study
por: Roy, Sanjoy, et al.
Publicado: (2011)

A new Hypoxic Ischemic Encephalopathy model in neonatal rats
por: Lyu, Hao, et al.
Publicado: (2021)

Gemcitabine Plus Anlotinib Is Effective and Safe Compared to Gemcitabine Plus Docetaxel in Advanced Soft Tissue Sarcoma
por: Liu, Zhiyong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uev7ibfaet0te50uhdrg5umu37